Q32 Bio (QTTB) Other Working Capital Changes (2017 - 2026)
Q32 Bio (QTTB) recorded quarterly Other Working Capital Changes of -$302000.0 in Q1 2026, up 79.04% quarter-over-quarter from -$1.4 million in Q4 2025, and down 102.68% on a YoY basis from $11.2 million in Q1 2025.
Q32 Bio (QTTB) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Q32 Bio's Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$302000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 102.68% year-over-year to -$302000.0; the TTM figure through Mar 2026 stood at -$2.0 million (down 325.91% YoY), while the FY2025 annual figure was -$1.9 million, down 586.96% from the prior year.
- Other Working Capital Changes was -$302000.0 for Q1 2026 at Q32 Bio, up from -$1.4 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $6.9 million in Q2 2022 to a low of -$25.5 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged -$2.0 million across 5 years, with a median of -$336000.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes plunged 896.45% in 2022, then surged 5485.0% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at -$2.8 million in 2022, then plunged by 798.17% to -$25.5 million in 2023, then surged by 102.72% to $694000.0 in 2024, then plunged by 307.64% to -$1.4 million in 2025, then surged by 79.04% to -$302000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$302000.0 (Q1 2026), -$1.4 million (Q4 2025), and -$35000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Q32 Bio | 167.59 Mn | 116.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -302,000.00 |
| Mar 31, 2026 | -302,000.00 |
| Dec 31, 2025 | -1.44 Mn |
| Dec 31, 2025 | -1.44 Mn |
| Sep 30, 2025 | -35,000.00 |
| Sep 30, 2025 | -35,000.00 |
| Jun 30, 2025 | -271,000.00 |
| Jun 30, 2025 | -271,000.00 |
| Mar 31, 2025 | -149,000.00 |
| Mar 31, 2025 | -149,000.00 |
| Dec 31, 2024 | 694,000.00 |
| Dec 31, 2024 | 694,000.00 |
| Sep 30, 2024 | -755,000.00 |
| Sep 30, 2024 | -755,000.00 |
| Jun 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | -1.33 Mn |
| Mar 31, 2024 | -1.33 Mn |
| Dec 31, 2023 | -25.50 Mn |
| Dec 31, 2023 | -25.50 Mn |